Galmed Pharmaceuticals: 3Q Earnings Snapshot
TEL AVIV, Israel (AP) _ Galmed Pharmaceuticals Ltd. (GLMD) on Wednesday reported a loss of $4.5 million in its third quarter.
The Tel Aviv, Israel-based company said it had a loss of 21 cents per share.
The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 32 cents per share.
The company’s shares closed at $4.75. A year ago, they were trading at $11.38.